Back to Agenda
[V6-S1] Made in Academia: Seed Development Initiatives
Session Chair(s)
Hideki Hanaoka, MD, PhD
Chiba University Hospital, Japan
In Japan, there are 15 core clinical research centers receiving strong support from the government. Their academic expertise is integral to the field of seed development. Overcoming obstacles to transfer the results of basic research into clinical research is not easy for academia, and collaboration with pharmaceutical companies and regulatory agencies is indispensable. Furthermore, there are expectations for the development of a Japanese NIH and national strategy districts. In this session, we will focus on several examples of successful seed development in medical institutions. In addition, we will examine the issues, direction, and solutions of the possibilities and outputs of drug development from the strategic viewpoint on pharmaceutical affairs of regulatory agencies.
Speaker(s)
Drug Discovery: Role and Significance of Academia
Toshio Miyata, MD, PhD
Tohoku University, Japan
Associate Executive Vice President
Identification and Modification of Novel Anti-Microbial Peptide toward Topical Wound-Healing Drug
Hironori Nakagami, MD, PhD
Osaka University, Japan
Professor, United Graduate School of Child Development
A Clinical Trial for POEMS syndrome
Sonoko Misawa, MD, PhD
Chiba University Graduate of Medicine, Japan
Associate Professor, Department of Neurology
Have an account?